---
title: "Aligos Therapeutics (ALGS.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ALGS.US/norm.md"
symbol: "ALGS.US"
name: "Aligos Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/ALGS.US.md"
datetime: "2026-03-14T05:16:23.718Z"
locales:
  - [en](https://longbridge.com/en/quote/ALGS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALGS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALGS.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/ALGS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ALGS.US/norm.md)


# Aligos Therapeutics (ALGS.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.92 | -3.04 | -1.53 | -2.11 | -13.08 |
| ROE | -126.85% | -145.25% | -58.13% | 394.07% | -3111.30% |
| Revenue | 169000.00 | 741000.00 | 965000.00 | 311000.00 | 629000.00 |
| Net income | -19.88M | -31.54M | -15.86M | 43.09M | -82.15M |
| Operating income | -21.81M | -28.36M | -18.57M | -19.24M | -20.56M |
| Gross margin | -9981.66% | -3130.36% | -1348.29% | -4563.02% | -2448.65% |
| Net margin | -11763.91% | -4256.01% | -1643.83% | 13854.66% | -13060.41% |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 88.53M | 109.76M | 134.71M | 150.70M | 70.09M |
| Leverage | 1.65 | 1.53 | 1.32 | 1.29 | -2.42 |
| BVPS | 8.67 | 11.67 | 16.56 | 19.04 | -7.50 |
| Turnover | 0.0276 | 0.0267 | 0.0261 | 0.0235 | 0.0356 |
| Cash & STI | 77.84M | 99.10M | 122.94M | 137.86M | 56.94M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 4.96M | 5.62M | 6.12M | 6.86M | 7.33M |
| Net debt | -72.59M | -93.03M | -116.07M | -129.99M | -48.56M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -21.75M | -24.34M | -15.50M | -20.91M | -18.40M |
| Investing CF | -2.02M | 47.68M | -39.42M | -44.07M | 19.97M |
| Financing CF | 123000.00 | -53000.00 | -177000.00 | 101.74M | 97000.00 |
| Free CF | -13.61M | -13.87M | -8.68M | -13.88M | -10.51M |
| OCF coverage | -22889.47% | -11992.61% | -14094.55% | -48625.58% | -25919.72% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -92000.00 | -193000.00 | -109000.00 | -43000.00 | -28000.00 |